260 related articles for article (PubMed ID: 32083547)
41. Post-translational modifications of the major linear epitope 169-190aa of Ro60 kDa autoantigen alter the autoantibody binding.
Terzoglou AG; Routsias JG; Moutsopoulos HM; Tzioufas AG
Clin Exp Immunol; 2006 Oct; 146(1):60-5. PubMed ID: 16968399
[TBL] [Abstract][Full Text] [Related]
42. Anti-Ro52 antibodies are a risk factor for interstitial lung disease in primary Sjögren syndrome.
Buvry C; Cassagnes L; Tekath M; Artigues M; Pereira B; Rieu V; Le Guenno G; Tournadre A; Ruivard M; Grobost V
Respir Med; 2020 Mar; 163():105895. PubMed ID: 32056839
[TBL] [Abstract][Full Text] [Related]
43. Strong Association of the Myriad Discrete Speckled Nuclear Pattern With Anti-SS-A/Ro60 Antibodies: Consensus Experience of Four International Expert Centers.
Röber N; Dellavance A; Ingénito F; Reimer ML; Carballo OG; Conrad K; Chan EKL; Andrade LEC
Front Immunol; 2021; 12():730102. PubMed ID: 34675922
[TBL] [Abstract][Full Text] [Related]
44. Prevalence and clinical relevance of 52-kDa and 60-kDa Ro/SS-A autoantibodies in Japanese patients with systemic sclerosis.
Fujimoto M; Shimozuma M; Yazawa N; Kubo M; Ihn H; Sato S; Tamaki T; Kikuchi K; Tamaki K
Ann Rheum Dis; 1997 Nov; 56(11):667-70. PubMed ID: 9462169
[TBL] [Abstract][Full Text] [Related]
45. Presymptomatic autoantibodies in Sjögren's syndrome: what significance do they hold for the clinic?
Henriksson G
Expert Rev Clin Immunol; 2014 Jul; 10(7):815-7. PubMed ID: 24867307
[TBL] [Abstract][Full Text] [Related]
46. Salivary anti-Ro60 and anti-Ro52 antibody profiles to diagnose Sjogren's Syndrome.
Ching KH; Burbelo PD; Gonzalez-Begne M; Roberts ME; Coca A; Sanz I; Iadarola MJ
J Dent Res; 2011 Apr; 90(4):445-9. PubMed ID: 21212317
[TBL] [Abstract][Full Text] [Related]
47. Fine specificity of anti-Ro(SSA) autoantibodies and clinical manifestations in patients with systemic lupus erythematosus.
Zimmermann C; Smolen JS; Graninger W; Petera P; Fabini G; Hassfeld W; Höfler E; Steiner G
J Rheumatol; 1996 Nov; 23(11):1897-903. PubMed ID: 8923363
[TBL] [Abstract][Full Text] [Related]
48. Anti-Ro52 antibody is highly prevalent and a marker of better prognosis in patients with ovarian cancer.
Bogdanos DP; Gkoutzourelas A; Papadopoulos V; Liaskos C; Patrikiou E; Tsigalou C; Saratziotis A; Hajiioannou J; Scheper T; Meyer W; Sakkas LI; Papandreou C
Clin Chim Acta; 2021 Oct; 521():199-205. PubMed ID: 34245687
[TBL] [Abstract][Full Text] [Related]
49. Autoantibodies identify primary Sjögren's syndrome in patients lacking serum IgG specific for Ro/SS-A and La/SS-B.
Longobardi S; Lopez-Davis C; Khatri B; Georgescu C; Pritchett-Frazee C; Lawrence C; Rasmussen A; Radfar L; Scofield RH; Baer AN; Robinson SA; Darrah E; Axtell RC; Pardo G; Wren JD; Koelsch KA; Guthridge JM; James JA; Lessard CJ; Farris AD
Ann Rheum Dis; 2023 Sep; 82(9):1181-1190. PubMed ID: 37147113
[TBL] [Abstract][Full Text] [Related]
50. Rapid serological detection of autoantibodies associated with Sjögren's syndrome.
Burbelo PD; Ching KH; Issa AT; Loftus CM; Li Y; Satoh M; Reeves WH; Iadarola MJ
J Transl Med; 2009 Sep; 7():83. PubMed ID: 19778440
[TBL] [Abstract][Full Text] [Related]
51. Ro52 autoantibodies arise from self-reactive progenitors in a mother of a child with neonatal lupus.
Reed JH; Gorny MK; Li L; Cardozo T; Buyon JP; Clancy RM
J Autoimmun; 2017 May; 79():99-104. PubMed ID: 28118945
[TBL] [Abstract][Full Text] [Related]
52. Highlights on novel technologies for the detection of antibodies to Ro60, Ro52, and SS-B.
Infantino M; Bentow C; Seaman A; Benucci M; Atzeni F; Sarzi-Puttini P; Olivito B; Meacci F; Manfredi M; Mahler M
Clin Dev Immunol; 2013; 2013():978202. PubMed ID: 24376466
[TBL] [Abstract][Full Text] [Related]
53. Anti-Ro52 antibodies frequently co-occur with anti-Jo-1 antibodies in sera from patients with idiopathic inflammatory myopathy.
Rutjes SA; Vree Egberts WT; Jongen P; Van Den Hoogen F; Pruijn GJ; Van Venrooij WJ
Clin Exp Immunol; 1997 Jul; 109(1):32-40. PubMed ID: 9218821
[TBL] [Abstract][Full Text] [Related]
54. Antibodies to Ro/SS-A and La/SS-B in systemic lupus erythematosus and other autoimmune disorders.
Pradhan VD; Badakere SS; Bichile LS; Dolas MP
J Assoc Physicians India; 2002 Jun; 50():762-5. PubMed ID: 12240838
[TBL] [Abstract][Full Text] [Related]
55. Anti-La positive, anti-Ro negative subset of primary Sjögren's syndrome: anti-La is a reality but is the disease?
Danda D; Sharma R; Truong D; Koelsch KA; Kurien BT; Bagavant H; Deshmukh U; Kaufman CE; Lewis DM; Stone DU; Radfar L; Rasmussen A; Sivils KL; Scofield RH
Clin Exp Rheumatol; 2017; 35(3):438-444. PubMed ID: 28229827
[TBL] [Abstract][Full Text] [Related]
56. Obstetric and perinatal outcome in anti-Ro/SSA-positive pregnant women: a prospective cohort study.
Martínez-Sánchez N; Pérez-Pinto S; Robles-Marhuenda Á; Arnalich-Fernández F; Martín Cameán M; Hueso Zalvide E; Bartha JL
Immunol Res; 2017 Apr; 65(2):487-494. PubMed ID: 28138914
[TBL] [Abstract][Full Text] [Related]
57. [Advances in autoantibodies and primary Sjogren's syndrome: An update].
Cai X; Zhou Y; Li H; Wu Z
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2021 Jun; 37(6):563-568. PubMed ID: 34060451
[TBL] [Abstract][Full Text] [Related]
58. Autoantibodies to small nuclear ribonucleoproteins. A strong association between anti-SS-B(La), HLA-B8, and Sjögren's syndrome.
Whittingham S; Mackay IR; Tait BD
Aust N Z J Med; 1983 Dec; 13(6):565-70. PubMed ID: 6609699
[TBL] [Abstract][Full Text] [Related]
59. Associations between anti-Ro52 antibodies and lung fibrosis in mixed connective tissue disease.
Gunnarsson R; El-Hage F; Aaløkken TM; Reiseter S; Lund MB; Garen T; ; Molberg Ø
Rheumatology (Oxford); 2016 Jan; 55(1):103-8. PubMed ID: 26320136
[TBL] [Abstract][Full Text] [Related]
60. Autoantibodies to the functionally active RING-domain of Ro52/SSA are associated with disease activity in patients with lupus.
Kvarnström M; Dzikaite-Ottosson V; Ottosson L; Gustafsson JT; Gunnarsson I; Svenungsson E; Wahren-Herlenius M
Lupus; 2013 Apr; 22(5):477-85. PubMed ID: 23554036
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
